Centene Management
Management criteria checks 1/4
Centene's CEO is Sarah London, appointed in Mar 2022, has a tenure of 2.67 years. total yearly compensation is $18.56M, comprised of 7.5% salary and 92.5% bonuses, including company stock and options. directly owns 0.035% of the company’s shares, worth $10.32M. The average tenure of the management team and the board of directors is 3.5 years and 2.8 years respectively.
Key information
Sarah London
Chief executive officer
US$18.6m
Total compensation
| CEO salary percentage | 7.5% |
| CEO tenure | 2.7yrs |
| CEO ownership | 0.04% |
| Management average tenure | 3.5yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024
Oct 22Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch
Oct 14
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?
Sep 26Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger
Sep 08Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Aug 20Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 02Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching
Jun 22A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price
Jun 04Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
May 14These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$19m | US$1m | US$3b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$13m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$1b |
| Dec 31 2021 | US$15m | US$978k | US$1b |
Compensation vs Market: Sarah's total compensation ($USD18.56M) is above average for companies of similar size in the US market ($USD12.73M).
Compensation vs Earnings: Sarah's compensation has increased by more than 20% in the past year.
CEO
Sarah London (43 yo)
2.7yrs
Tenure
US$18,556,966
Compensation
Ms. Sarah M. London has been the Chief Executive Officer of Centene Corporation since March 21, 2022 and serves as its Director since September 2021. She served as President of Health Care Enterprises and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.7yrs | US$18.56m | 0.035% $ 10.3m | |
| President | 1.9yrs | US$10.62m | 0.016% $ 4.6m | |
| Executive VP & CFO | 3.5yrs | US$9.91m | 0.046% $ 13.6m | |
| Executive VP | 4.8yrs | US$4.84m | 0.019% $ 5.7m | |
| CEO of Markets & Medicaid | 5.8yrs | US$6.20m | 0.0094% $ 2.7m | |
| Chief Operating Officer | less than a year | no data | 0.0022% $ 647.9k | |
| Senior VP | 3.6yrs | no data | 0.0056% $ 1.6m | |
| Chief Information Officer | 1.9yrs | no data | no data | |
| Senior Vice President of Investor Relations | 4.6yrs | no data | no data | |
| Chief Risk | 2.2yrs | no data | no data | |
| Senior VP & Chief Marketing Officer | 3.5yrs | no data | no data | |
| Executive Vice President of Global Human Resources | 3.7yrs | no data | no data |
3.5yrs
Average Tenure
56.5yo
Average Age
Experienced Management: CNC's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.2yrs | US$18.56m | 0.035% $ 10.3m | |
| Independent Director | 2yrs | US$324.98k | 0.00086% $ 251.0k | |
| Independent Chairman | 18.6yrs | US$537.45k | 0.069% $ 20.1m | |
| Independent Director | 2.8yrs | US$369.98k | 0.0046% $ 1.4m | |
| Lead Independent Director | 4.8yrs | US$474.98k | 0.0074% $ 2.2m | |
| Independent Director | 2.8yrs | US$372.48k | 0.0022% $ 656.7k | |
| Director | less than a year | no data | no data | |
| Independent Director | 2.8yrs | US$349.98k | 0.0057% $ 1.7m | |
| Director | 2.8yrs | US$1.25m | 0.088% $ 25.8m | |
| Independent Director | 6.8yrs | US$344.98k | 0.0043% $ 1.3m | |
| Independent Director | 5.1yrs | US$299.98k | 0.0023% $ 662.5k |
2.8yrs
Average Tenure
65yo
Average Age
Experienced Board: CNC's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.